ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

NIH Panel Calls for Further Research On End-of-Life Issues.

January 21, 2005

Breast Cancer Death Rates Improving, NCI Says

May 10, 1996

Partnership Points to New Path Forward For Drug Approval and Clinical Research

June 20, 2014

In Brief: ASTRO Elects New Officers; ASSIST Coordinators Express Concern Over NCI Plan To Cut Budget

November 27, 1992

NCCN, ACS Offer Publication For Patients About Nausea.

June 22, 2001

In Brief: President’s Request For NCI FY 1981 Budget: Same As 1980; New Clinical Study Section Option Open

December 14, 1979